OptiNose, Inc.
OPTN
$9.32
-$0.02-0.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 78.23M | 75.67M | 75.06M | 74.02M | 70.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.23M | 75.67M | 75.06M | 74.02M | 70.99M |
| Cost of Revenue | 7.23M | 7.41M | 7.57M | 8.16M | 8.63M |
| Gross Profit | 71.00M | 68.26M | 67.49M | 65.86M | 62.36M |
| SG&A Expenses | 83.46M | 83.08M | 81.62M | 77.59M | 79.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 94.55M | 94.86M | 93.89M | 90.48M | 93.73M |
| Operating Income | -16.32M | -19.19M | -18.83M | -16.45M | -22.75M |
| Income Before Tax | -21.62M | -31.22M | -40.91M | -30.76M | -35.54M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.62 | -31.22 | -40.91 | -30.76 | -35.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.62M | -31.22M | -40.91M | -30.76M | -35.54M |
| EBIT | -16.32M | -19.19M | -18.83M | -16.45M | -22.75M |
| EBITDA | -16.04M | -18.85M | -18.45M | -16.04M | -22.34M |
| EPS Basic | -2.64 | -3.94 | -5.22 | -4.10 | -4.76 |
| Normalized Basic EPS | -1.65 | -2.46 | -3.26 | -2.56 | -2.97 |
| EPS Diluted | -2.93 | -4.23 | -5.51 | -4.15 | -4.82 |
| Normalized Diluted EPS | -1.64 | -2.45 | -3.25 | -2.56 | -2.97 |
| Average Basic Shares Outstanding | 40.59M | 36.45M | 32.31M | 29.94M | 29.89M |
| Average Diluted Shares Outstanding | 40.81M | 36.67M | 32.52M | 29.95M | 29.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |